Inventor · disambiguated record

Avinash Phadke

Also filed as: PHADKE AVINASH · PHADKE AVINASH S

93 granted patents·24 pending applications·1,484 citations·filing 1998–2024

99Inventor score

Technology areasA61P C07D A61K C07F C07B

Files withACHILLION PHARMACEUTICALS INC88 MIRAVANT PHARM INC5 JANSSEN PHARMACEUTICALS INC4 PHADKE AVINASH4 WILES JASON ALLAN3

Top patents by PatentIndex Score

117 records

0199US10822352B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 3, 2020·20 cites·17 claims
0299US10550140B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 4, 2020·27 cites·20 claims
0399US10301336B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 28, 2019·27 cites·20 claims
0499US10287301B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 14, 2019·28 cites·18 claims
0599US10189869B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Jan 29, 2019·27 cites·36 claims
0699US10138225B2Amide compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Nov 27, 2018·33 cites·31 claims
0799US10106563B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 23, 2018·30 cites·20 claims
0899US10100072B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 16, 2018·27 cites·53 claims
0999US10092547B2Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infectionsACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·19 cites·14 claims
1099US10081645B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Sep 25, 2018·27 cites·40 claims
1199US10011612B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jul 3, 2018·30 cites·3 claims
1299US10005802B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jun 26, 2018·27 cites·38 claims
1399US10000516B2Phosphonate compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jun 19, 2018·28 cites·28 claims
1499US9828396B2Alkyne compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·30 cites·40 claims
1599US9796741B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Oct 24, 2017·37 cites·50 claims
1699US9758537B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Sep 12, 2017·27 cites·39 claims
1799US9732103B2Carbamate, ester, and ketone compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·32 cites·29 claims
1899US9732104B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·30 cites·68 claims
1999US9695205B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·32 cites·56 claims
2099US9663543B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·32 cites·49 claims
2199US9598446B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Mar 21, 2017·33 cites·7 claims
2298US11708351B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·8 cites·17 claims
2398US11407738B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·16 cites·12 claims
2498US11084800B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·18 cites·11 claims
2598US10919884B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 16, 2021·20 cites·12 claims
2698US10906887B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 2, 2021·20 cites·12 claims
2798US10689409B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Jun 23, 2020·9 cites·23 claims
2898US10662175B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·20 cites·20 claims
2998US10464956B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 5, 2019·21 cites·24 claims
3098US10428095B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Oct 1, 2019·21 cites·2 claims
3198US10428094B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 1, 2019·21 cites·40 claims
3298US10370394B2Carbamate, ester, and ketone compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·23 cites·35 claims
3398US10253053B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Apr 9, 2019·22 cites·20 claims
3498US10087203B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·25 cites·21 claims
3597US12006307B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2022·Granted Jun 11, 2024·3 cites·7 claims
3697US11447465B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Sep 20, 2022·16 cites·8 claims
3797US11053253B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Jul 6, 2021·16 cites·9 claims
3897US11001600B2Disubstituted compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 11, 2021·16 cites·9 claims
3997US10807952B2Compounds for treatment of immune inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Oct 20, 2020·20 cites·13 claims
4097US10660876B2Amino compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·20 cites·14 claims
4197US7906619B24-amino-4-oxobutanoyl peptides as inhibitors of viral replicationACHILLION PHARMACEUTICALS INC·Filed 2007·Granted Mar 15, 2011·51 cites·28 claims
4296US12162860B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·2 cites·20 claims
4396US11718626B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Aug 8, 2023·3 cites·21 claims
4496US10092584B2Compounds for the treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Oct 9, 2018·28 cites·41 claims
4596US9273082B2Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infectionsACHILLION PHARMACEUTICALS INC·Filed 2014·Granted Mar 1, 2016·14 cites·17 claims
4695US12139497B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Nov 12, 2024·1 cites·20 claims
4795US11649229B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
4895US11649223B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
4995US10385097B2Ether compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Aug 20, 2019·23 cites·27 claims
5095US9125904B1Biphenyl imidazoles and related compounds useful for treating HCV infectionsWILES JASON ALLAN·Filed 2011·Granted Sep 8, 2015·17 cites·7 claims

Showing the top 50 of 117 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Avinash Phadke files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →